United States · FDA National Drug Code directory
GRAFAPEX
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59137-365_2d06b03c-17aa-0492-e063-6294a90abd8f
- Product NDC
- 59137-365
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- treosulfan
- Labeler
- Medexus Pharma, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20250128
- Source listing expiry
- 20261231
Source-listed ingredients
- TREOSULFAN — 5000 mg/5g
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (59137-365-01) / 5 g in 1 VIAL · 59137-365-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →